1 completed, 1 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
Follow Doxercalciferol: new trials by email Literature Review of Doxercalciferol trials Research Report on Doxercalciferol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT) CTAP201 Injection, Doxercalciferol - Chronic Kidney Disease, Secondary Hyperparathyroidism | Phase 1 | Completed | OPKO IP Holdings II, Inc. | 24 | 2008-11-01 | 2014-09-29 |
| Doxercalciferol in Recurrent Pediatric Solid Tumors Doxercalciferol - Solid Tumors | Phase 1 | Terminated | M.D. Anderson Cancer Center | 1 | 2007-08-01 | 2012-07-31 |
Hyperparathyroidism (1) · Hyperparathyroidism, Secondary (1) · Kidney Diseases (1) · Kidney Failure, Chronic (1) · Neoplasms (1) · Parathyroid Diseases (1) · Renal Insufficiency (1) · Renal Insufficiency, Chronic (1)
M.D. Anderson Cancer Center (1) · OPKO IP Holdings II, Inc. (1)
United States (2)
Joel Melnick, MD (1) · Peter E. Zage, MD, PhD (1)